Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Antibody Drug Conjugates (ADC). These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN107531680B reveals a novel route for toxin intermediates, offering high optical purity and yield for cost reduction in ADC toxin manufacturing.